Sensient Colors, LLC.; Filing of Color Additive Petition, 8537-8538 [2024-02576]
Download as PDF
lotter on DSK11XQN23PROD with RULES1
Federal Register / Vol. 89, No. 27 / Thursday, February 8, 2024 / Rules and Regulations
management system will be deemed to
be signed by that person.
(4) Conform to standard letter
dimensions (8.5 x 11 inches).
(b) Redacted filings and exhibits. Any
person who files a pleading, exhibit, or
other document that contains an
individual’s social security number,
taxpayer-identification number, or birth
date; the name of an individual known
to be a minor; or a financial-account
number, must redact all such
information, except the last four digits
of the social security number and
taxpayer-identification number; the year
of the individual’s birth; the minor’s
initials; and the last four digits of the
financial-account number.
(c) Nonelectronic filings. All
nonelectronic pleadings filed with the
Board must be secured at the top. For
each pleading filed with the Board, the
original and two legible copies must be
submitted. Nonelectronic filings must
be sent to the U.S. Department of Labor,
Benefits Review Board, ATTN: Office of
the Clerk of the Appellate Boards
(OCAB), 200 Constitution Ave. NW,
Washington, DC 20210–0001, or
otherwise presented to the Clerk.
(d) Electronic filings. (1) Except as
provided in paragraph (d)(2) of this
section, beginning on March 11, 2024,
attorneys and lay representatives must
be registered with the Board’s electronic
case management system and file all
pleadings, exhibits, and other
documents with the Board through this
system (e-file). All e-filed documents
must be in Portable Document Format
(PDF). The Board prefers that pleadings
be filed in text-searchable PDF format.
Paper copies are not required unless
requested by the Board.
(2) Attorneys and lay representatives
may request an exemption (pursuant to
§ 802.219) for good cause shown. Such
a request must include a detailed
explanation why e-filing or acceptance
of e-service should not be required.
(3) Self-represented parties may file
pleadings, exhibits, and other
documents in electronic or
nonelectronic form in accordance with
paragraph (c) or (d) of this section.
(4) A document filed electronically is
a written paper for purposes of this Part.
(5) A person who is adversely affected
by a technical failure in connection with
filing or receipt of an electronic
document may seek appropriate relief
from the Board under § 802.219. If a
technical malfunction or other issue
prevents access to the Board’s case
management system for a protracted
period, the Board by special order may
provide appropriate relief pending
restoration of electronic access.
VerDate Sep<11>2014
16:18 Feb 07, 2024
Jkt 262001
(e) Special rules for notices of appeal.
(1) Except as otherwise provided in this
section, a notice of appeal is considered
to have been filed only as of the date it
is received by the office of the Clerk of
the Board.
(2) A notice of appeal submitted to
any other agency or subdivision of the
Department of Labor or of the U.S.
Government or any state government,
and subsequently received by the office
of the Clerk of the Board, will be
considered filed with the Clerk of the
Board as of the date it was received by
the other governmental unit if the Board
finds in its discretion that it is in the
interest of justice to do so.
(3) If the notice of appeal is sent by
mail or commercial carrier and the
fixing of the date of delivery as the date
of filing would result in a loss or
impairment of appeal rights, it will be
considered to have been filed as of the
date of mailing or the date of delivery
to the commercial carrier.
(i) For notices sent by mail, the date
appearing on the U.S. Postal Service
postmark (when available and legible)
will be prima facie evidence of the date
of mailing. If there is no such postmark
or it is not legible, other evidence such
as, but not limited to, certified mail
receipts, certificates of service, and
affidavits, may be used to establish the
mailing date.
(ii) For notices sent by commercial
carrier, the date of delivery to the carrier
may be demonstrated by the carrier’s
receipt or tracking information.
(4) If the notice of appeal is
electronically filed through the Board’s
case management system, it is
considered received by the office of the
Clerk of the Board as of the date and
time recorded by the system under
§ 802.221(c).
■ 6. Add § 802.223 to subpart B to read
as follows:
§ 802.223
Service requirements.
This section prescribes rules and
procedures for serving pleadings
(including notices of appeal, petitions
for review, and response briefs,
additional briefs, and motions), exhibits,
and other documents including routine
correspondence on other parties and
representatives.
(a) A copy of any document filed with
the Board must be served on each party
and the Solicitor of Labor by the party
filing the document.
(b) Manner of service. (1)
Nonelectronic service may be completed
by:
(i) Personal delivery;
(ii) Mail; or
(iii) Commercial delivery.
PO 00000
Frm 00013
Fmt 4700
Sfmt 4700
8537
(2) Electronic service may be
completed by:
(i) Electronic mail, if consented to in
writing by the person served; or
(ii) Sending it to a user registered with
the Board’s electronic case management
system by filing via this system. A
person who registers to use the Board’s
case management system is deemed to
have consented to accept service
through the system.
(c) When service is effected. (1)
Service by personal delivery is effected
on the date the document is delivered
to the recipient.
(2) Service by mail or commercial
carrier is effected on mailing or delivery
to the carrier.
(3) Service by electronic means is
effected on sending.
(d) Date of receipt for electronic
documents. Unless the party making
service is notified that the document
was not received by the party served—
(1) A document filed via the Board’s
case management system is considered
received by registered users on the date
it is sent by the system; and
(2) A document served via electronic
mail is considered received by the
recipient on the date it is sent.
Signed in Washington, DC.
Julie A. Su,
Acting Secretary of Labor.
[FR Doc. 2024–01991 Filed 2–7–24; 8:45 am]
BILLING CODE 4510–FN–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 73
[Docket No. FDA–2018–C–4117]
Sensient Colors, LLC.; Filing of Color
Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of petition.
The Food and Drug
Administration (FDA or we) is
announcing that we have filed a
petition, submitted by Sensient Colors,
LLC., proposing that we amend our
color additive regulations to provide for
the safe use of butterfly pea flower
extract in ready-to-eat cereals, crackers
and snack mixes, and chips at levels
consistent with good manufacturing
practice.
SUMMARY:
The color additive petition was
filed on December 5, 2023.
ADDRESSES: For access to the docket to
read background documents or
DATES:
E:\FR\FM\08FER1.SGM
08FER1
8538
Federal Register / Vol. 89, No. 27 / Thursday, February 8, 2024 / Rules and Regulations
comments received, go to https://
www.regulations.gov and insert the
docket number found in brackets in the
heading of this document into the
‘‘Search’’ box and follow the prompts,
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
DEPARTMENT OF JUSTICE
FOR FURTHER INFORMATION CONTACT:
Conforming Amendment Regarding
the Veterinary Medicine Mobility Act of
2014
Stephen DiFranco, Center for Food
Safety and Applied Nutrition, Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2710.
Under the
Federal Food, Drug, and Cosmetic Act
(section 721(d)(1) (21 U.S.C.
379e(d)(1))), we are giving notice that
we have filed a color additive petition
(CAP 4C0328), submitted by Exponent,
Inc., on behalf of Sensient Colors, LLC.,
1150 Connecticut Ave. NW, Suite 1100,
Washington, DC 20036. The petition
proposes to amend the color additive
regulations in § 73.69 (21 CFR 73.69)
Listing of Color Additives Exempt from
Certification: Butterfly pea flower
extract to expand the safe use of
butterfly pea flower extract to include
ready-to-eat cereals, crackers and snack
mixes, and chips at levels consistent
with good manufacturing practice.
The petitioner claims that this action
is categorically excluded under 21 CFR
25.32(k) because the substance is
intended to remain in food through
ingestion by consumers and is not
intended to replace macronutrients in
food. In addition, the petitioner states
that, to their knowledge, no
extraordinary circumstances exist. If
FDA determines a categorical exclusion
applies, neither an environmental
assessment nor an environmental
impact statement is required. If FDA
determines a categorical exclusion does
not apply, we will request an
environmental assessment and make it
available for public inspection.
SUPPLEMENTARY INFORMATION:
Dated: February 5, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–02576 Filed 2–7–24; 8:45 am]
lotter on DSK11XQN23PROD with RULES1
BILLING CODE 4164–01–P
Drug Enforcement Administration
21 CFR Part 1301
[Docket No. DEA–1043]
RIN 1117–AB82
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Final rule.
AGENCY:
The Veterinary Medicine
Mobility Act of 2014 (VMMA), which
became law on August 1, 2014,
amended the Controlled Substances Act
to address separate registration
requirements for veterinarians. The
VMMA allows a veterinarian to
transport and dispense controlled
substances in the usual course of
veterinary practice at a site other than
the veterinarian’s registered principal
place of business or professional
practice without obtaining a separate
registration, subject to certain
limitations. The Drug Enforcement
Administration is amending its
regulations to codify the VMMA. This
rule merely conforms DEA regulations
to statutory amendments of the
Controlled Substances Act that have
already taken effect and makes no
substantive change to existing legal
requirements.
SUMMARY:
This final rule is effective on
February 8, 2024.
FOR FURTHER INFORMATION CONTACT:
Scott A. Brinks, Regulatory Drafting and
Policy Support Section, Diversion
Control Division, Drug Enforcement
Administration; Telephone: (571) 776–
3882.
DATES:
SUPPLEMENTARY INFORMATION:
Legal Authority
The Drug Enforcement
Administration (DEA) implements and
enforces the Comprehensive Drug Abuse
Prevention and Control Act of 1970,
often referred to as the Controlled
Substances Act (CSA) and the
Controlled Substances Import and
Export Act, as amended.1 The CSA and
its implementing regulations are
designed to prevent, detect, and
eliminate the diversion of controlled
substances and listed chemicals into the
illicit market while providing for the
legitimate medical, scientific, research,
and industrial needs of the United
States. DEA publishes the implementing
regulations for these statutes in 21 CFR
parts 1300 to 1399.
On August 1, 2014, the President
signed the Veterinary Medicine Mobility
Act of 2014 (VMMA) into law as Public
Law 113–143.2 The VMMA amended
section 302(e) of the CSA to address
separate registration requirements for
veterinarians. Specifically, the VMMA
redesignated 21 U.S.C. 822(e) as 21
U.S.C. 822(e)(1) and added a new
paragraph, 21 U.S.C. 822(e)(2). The
newly added 21 U.S.C. 822(e)(2)
provides that ‘‘. . . a registrant who is
a veterinarian shall not be required to
have a separate registration in order to
transport and dispense controlled
substances in the usual course of
veterinary practice at a site other than
the registrant’s registered principal
place of business or professional
practice, so long as the site of
transporting and dispensing is located
in a State where the veterinarian is
licensed to practice veterinary medicine
and is not a principal place of business
or professional practice.’’ In this final
rule, DEA is amending its regulations to
conform to the change to the CSA made
by the VMMA.
Regulatory Analysis
Administrative Procedure Act
Under the Administrative Procedure
Act (APA),3 agencies generally offer
interested parties the opportunity to
comment on proposed regulations
before they become effective. However,
an agency may find good cause to
exempt a rule from certain provisions of
the APA, including those requiring the
publication of a prior notice of proposed
rulemaking and the opportunity for
public comment, if such actions are
determined to be unnecessary,
impracticable, or contrary to the public
interest. DEA finds there is good cause
within the meaning of the APA to issue
this amendment as a final rule without
opportunity for public comment and
with an immediate effective date
because such comment is unnecessary.
This final rule amends DEA
regulations simply to incorporate the
provisions of the VMMA. The legal
requirements articulated in this final
rule are already in effect by virtue of the
VMMA. This rule merely incorporates
the statutory provision into DEA
regulations.
DEA is publishing this as a final rule
because notice of proposed rulemaking
and solicitation of public comment is
2 Public
1 21
VerDate Sep<11>2014
16:18 Feb 07, 2024
Jkt 262001
PO 00000
U.S.C. 801–971.
Frm 00014
Fmt 4700
35
Sfmt 4700
Law 113–143, 128 Stat. 1750 (2014).
U.S.C. 553.
E:\FR\FM\08FER1.SGM
08FER1
Agencies
[Federal Register Volume 89, Number 27 (Thursday, February 8, 2024)]
[Rules and Regulations]
[Pages 8537-8538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02576]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 73
[Docket No. FDA-2018-C-4117]
Sensient Colors, LLC.; Filing of Color Additive Petition
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of petition.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that we have filed a petition, submitted by Sensient Colors, LLC.,
proposing that we amend our color additive regulations to provide for
the safe use of butterfly pea flower extract in ready-to-eat cereals,
crackers and snack mixes, and chips at levels consistent with good
manufacturing practice.
DATES: The color additive petition was filed on December 5, 2023.
ADDRESSES: For access to the docket to read background documents or
[[Page 8538]]
comments received, go to https://www.regulations.gov and insert the
docket number found in brackets in the heading of this document into
the ``Search'' box and follow the prompts, and/or go to the Dockets
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Stephen DiFranco, Center for Food
Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240-402-2710.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 721(d)(1) (21 U.S.C. 379e(d)(1))), we are giving notice
that we have filed a color additive petition (CAP 4C0328), submitted by
Exponent, Inc., on behalf of Sensient Colors, LLC., 1150 Connecticut
Ave. NW, Suite 1100, Washington, DC 20036. The petition proposes to
amend the color additive regulations in Sec. 73.69 (21 CFR 73.69)
Listing of Color Additives Exempt from Certification: Butterfly pea
flower extract to expand the safe use of butterfly pea flower extract
to include ready-to-eat cereals, crackers and snack mixes, and chips at
levels consistent with good manufacturing practice.
The petitioner claims that this action is categorically excluded
under 21 CFR 25.32(k) because the substance is intended to remain in
food through ingestion by consumers and is not intended to replace
macronutrients in food. In addition, the petitioner states that, to
their knowledge, no extraordinary circumstances exist. If FDA
determines a categorical exclusion applies, neither an environmental
assessment nor an environmental impact statement is required. If FDA
determines a categorical exclusion does not apply, we will request an
environmental assessment and make it available for public inspection.
Dated: February 5, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-02576 Filed 2-7-24; 8:45 am]
BILLING CODE 4164-01-P